ID: ALA3707937
Type: Binding
Description: In Vitro Assay: The in vitro affinity of the compounds of the present invention for the CXCR1 and CXCR2 receptors was determined on a functional test of the .beta.-arrestin recruitment type after receptor activation.It was demonstrated that the activation by CXCL8 of the CXCR2 receptor in cells of the PathHunter HEK293-CXCR2 line or of the CXCR1 receptor in cells of the U2OS h CXCR1 .beta.-arrestin line results in the recruitment of .beta.-arrestin (Richardson et al. 2003 Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.)In order to evaluate the direct interaction of the CXCR2 or CXCR1 receptor with .beta.-arrestin 2, a .beta.-arrestin 2 recruitment test for CXCR2 or CXCR1 based on of .beta.-galactosidase enzyme complementation (Olson K R, Eglen R M. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol. 2007 February; 5(1); 137-44).
Organism: Homo sapiens
Bioactivity
Activity Types for Assay ALA3707937
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
457.46 | 2.47 | 2.47 |
453.50 | 2.91 | 2.91 |
481.51 | 2.03 | 2.03 |
481.51 | 2.03 | 2.03 |
565.62 | 3.77 | 3.77 |
523.54 | 2.60 | 2.60 |
523.54 | 2.60 | 2.60 |
412.44 | 2.88 | 2.88 |
438.48 | 3.66 | 3.66 |
465.51 | 3.06 | 3.06 |
481.51 | 2.30 | 2.30 |
383.40 | 1.82 | 1.82 |
369.38 | 2.22 | 2.22 |
475.52 | 2.07 | 2.07 |
509.97 | 2.73 | 2.73 |
445.50 | 2.59 | 2.59 |
453.50 | 2.83 | 2.83 |
465.51 | 2.63 | 2.63 |
465.51 | 2.63 | 2.63 |
479.49 | 2.35 | 2.35 |
465.51 | 2.32 | 2.32 |
523.54 | 2.60 | 2.60 |
441.51 | 2.68 | 2.68 |
455.54 | 2.99 | 2.99 |
425.44 | 2.22 | 2.22 |
439.47 | 2.52 | 2.52 |
467.52 | 3.34 | 3.34 |
399.40 | 2.23 | 2.23 |
403.82 | 2.87 | 2.87 |
393.40 | 2.69 | 2.69 |
507.47 | 3.46 | 3.46 |
439.47 | 2.52 | 2.52 |
453.50 | 2.91 | 2.91 |
473.91 | 3.18 | 3.18 |
565.05 | 2.41 | 2.41 |
439.47 | 2.52 | 2.52 |